RxDoctor Payments Data

Nicholas Beckmann, DO

Otolaryngology · Colorado Springs, CONPI 1891114260

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $114,064 of the $151,179 with a category attached, or 75.4%. Inspire Medical Systems, Inc. accounts for 98.8% of it on its own, with 17 other manufacturers making up the rest. 2025 is the largest year on record at $85,961, more than ten times the $157 reported in 2019. Among otolaryngology clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$151,179in general payments, 2019–2025

Across 234 payments — averaging $646.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$149K
  • Smith+Nephew$322
  • AstraZeneca$278
  • Medtronic$265
  • Aerin Medical Inc.$187
  • GSK$183
  • plus $511 from 12 others
$7,050in research payments, 2019–2025

Across 2 payments — averaging $3525.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Inspire Medical Systems, Inc.$7K

What the payments were for

  • Consulting fees$114,06475%
  • Speaking & faculty fees$20,00013%
  • Travel & lodging$8,8706%
  • Food & beverage$8,0705%
  • Education$1760%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$151,179 in reported general payments places this provider in the 95th percentile of 174 otolaryngology providers in Colorado.

See all otolaryngology providers in Colorado

Medicare billing

Part B allowed, 2024
$249,286
Medicare patients
391
Services billed
1,274

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine-FluticasoneAzelastine/Fluticasone62$8,555
Ipratropium Bromide100$3,638
Azelastine Hcl59$1,743
Fluticasone Propionate52$795
Fluocinolone Acetonide Oil14$566
Cefdinir21$301
Cephalexin76$299
Ondansetron OdtOndansetron67$290
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen112$281
Ofloxacin11$208
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$152
Methylprednisolone12$77

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Colorado Springs

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →